pI: 7.0308 |
Length (AA): 536 |
MW (Da): 60170 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
152 | 533 | 2bvc (A) | 4 | 409 | 18.00 | 0 | 1 | 0.75 | 0.19 |
155 | 512 | 2d3a (A) | 5 | 352 | 45.00 | 0 | 1 | 1.16 | -0.57 |
138 | 516 | 2ojw (A) | 2 | 364 | 45.00 | 0 | 1 | 1.26409 | -0.83 |
160 | 512 | 2d3a (A) | 13 | 352 | 48.00 | 0 | 1 | 1.25138 | -0.92 |
170 | 527 | 3fky (A) | 28 | 364 | 49.00 | 0 | 1 | 1.22271 | -0.74 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_127569)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G48470 | 5 |
Arabidopsis thaliana | AT5G37600 | glutamine synthetase 1 |
Arabidopsis thaliana | AT3G17820 | glutamine synthetase cytosolic isozyme 1-3 |
Arabidopsis thaliana | AT5G16570 | 4 |
Arabidopsis thaliana | AT5G35630 | glutamine synthetase 2 |
Brugia malayi | Bm1_53470 | glutamine synthetase |
Candida albicans | CaO19.646 | likely glutamine synthetase similar to S. cerevisiae GLN1 (YPR035W) |
Candida albicans | CaO19.8260 | likely glutamine synthetase similar to S. cerevisiae GLN1 (YPR035W) |
Caenorhabditis elegans | CELE_Y105C5B.28 | Protein GLN-3, isoform C |
Drosophila melanogaster | Dmel_CG2718 | Glutamine synthetase 1 |
Drosophila melanogaster | Dmel_CG1743 | Glutamine synthetase 2 |
Echinococcus granulosus | EgrG_000959900 | glutamine synthetase |
Echinococcus multilocularis | EmuJ_000959900 | glutamine synthetase |
Homo sapiens | ENSG00000135821 | glutamate-ammonia ligase |
Leishmania braziliensis | LbrM.06.0350 | glutamine synthetase, putative |
Leishmania donovani | LdBPK_060370.1 | glutamine synthetase, putative |
Leishmania infantum | LinJ.06.0370 | glutamine synthetase, putative |
Leishmania major | LmjF.06.0370 | glutamine synthetase, putative |
Leishmania mexicana | LmxM.06.0370 | glutamine synthetase, putative |
Mus musculus | ENSMUSG00000026473 | glutamate-ammonia ligase (glutamine synthetase) |
Oryza sativa | 4333896 | Os03g0712800 |
Oryza sativa | 4337272 | Os04g0659100 |
Oryza sativa | 4330649 | Os02g0735200 |
Oryza sativa | 4332108 | Os03g0223400 |
Saccharomyces cerevisiae | YPR035W | glutamate--ammonia ligase |
Schistosoma japonicum | Sjp_0041380 | ko:K01915 glutamine synthetase [EC6.3.1.2], putative |
Schistosoma mansoni | Smp_091460 | glutamine synthetase 1 2 (glutamate-amonia ligase) (gs) |
Schmidtea mediterranea | mk4.006595.00 | Glutamine synthetase |
Schmidtea mediterranea | mk4.000905.09 | Glutamine synthetase |
Schmidtea mediterranea | mk4.002580.02 | |
Schmidtea mediterranea | mk4.002580.01 | Glutamine synthetase |
Schmidtea mediterranea | mk4.000905.06 | Glutamine synthetase |
Schmidtea mediterranea | mk4.000905.08 | |
Schmidtea mediterranea | mk4.000905.04 | Glutamine synthetase |
Schmidtea mediterranea | mk4.000876.02 | |
Trypanosoma brucei gambiense | Tbg972.7.5700 | glutamine synthetase, putative |
Trypanosoma brucei | Tb927.7.4970 | glutamine synthetase, putative |
Trypanosoma congolense | TcIL3000_7_4160 | glutamine synthetase, putative |
Trypanosoma cruzi | TcCLB.508175.370 | glutamine synthetase, putative |
Trypanosoma cruzi | TcCLB.503405.10 | glutamine synthetase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.7.4970 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.7.4970 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.7.4970 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.7.4970 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
YPR035W | Saccharomyces cerevisiae | inviable | yeastgenome |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.6
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Zea mays | Glutamine synthetase, chloroplastic | Compounds | References |
Homo sapiens | glutamate-ammonia ligase | Compounds | References |
Oryza sativa | Os04g0659100 | Compounds | References |